ESCO (NYSE:ESE) Misses Q2 CY2026 Revenue Estimates

ESCO (NYSE:ESE) reported Q2 CY2026 revenue of $339 million, up 14.4% year on year, but below analysts’ estimates. Full-year revenue guidance was $1.32 billion at the midpoint, near consensus. Non-GAAP adjusted EPS was $2.20, 3.9% above consensus. The stock fell 1.1% to $324.21 after the report.

Original reporting
Published Aug 6, 2026, 10:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 10:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ESCO (NYSE:ESE) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$ESENeutralMed
01

Why it matters

Traders can reassess near-term demand and margin durability using the revenue miss, EPS beat, and guidance positioning versus consensus.

02

Market read

Q2 shows revenue underperformance versus estimates but profitable EPS outperformance, with full-year revenue near consensus and EPS guidance ahead, creating a mixed setup for the stock.

03

What to watch

The article notes EBITDA fell slightly short and cites analyst expectations for revenue growth decelerating to 7.2%, which could matter more than the EPS beat for valuation.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction following Q2 results

Background

ESCO is an engineered products manufacturer serving aerospace, defense, and utility markets, and the article frames its Q2 performance versus Wall Street expectations.

Company-level read

Ticker impact

$ESENeutralMedium confidence
Context

ESCO reported Q2 CY2026 revenue of $339M, up 14.4% YoY but below Wall Street estimates, while adjusted EPS was $2.20 and beat consensus.

Expected impact

Near-term volatility likely, with downside risk if investors focus on the revenue miss and demand deceleration.

Evidence & confidence

The article provides concrete Q2 results (revenue miss, EPS beat) plus full-year revenue and EPS guidance versus consensus, which typically drives immediate repricing and sets a near-term narrative for demand.

Market effects

Defense and aerospace component suppliers may see read-through on near-term demand expectations if revenue misses persist.

No specific regional spillover beyond US industrials sentiment.

Limited global relevance; impacts are primarily within US industrials/defense supply chain expectations.

Counterpoint

The revenue miss may be temporary given full-year revenue guidance is near consensus and operating margin stability suggests costs are controlled.

Key entities

  • ESCO

    NYSE-listed engineered products manufacturer reporting Q2 CY2026 results and full-year guidance.

  • Wall Street estimates

    Consensus benchmarks for Q2 revenue, adjusted EPS, and full-year guidance cited in the article.

Related articles

$ESEMedAI 8/10

ESCO (ESE) Q3 2026 Earnings Call Transcript

ESCO Technologies (ESE) reported Q3 2026 consolidated sales of $339M (+14% YoY) and adjusted EPS of $2.20 (+38%). Book-to-bill was 1.21 and backlog $1.54B. Full-year 2026 guidance: sales $1.30B-$1.33B and adjusted EPS $8.30-$8.40. Management discussed pending Megger acquisition and debt cost near 6%.

Med

DroneShield Shares Down 50% This Year, As Pressure Builds

DroneShield (ASX: DRO) shares have fallen 50% in 2026, despite a 74% revenue increase to A$125.8M. The company reported a net loss of A$32.2M, causing concern about profitability. Brokers have mixed price targets, ranging from A$1.50 to A$2.60. The stock trades at A$1.66, below the A$1.70 support level.

$KBHMedAI 8/10

KB Home’s (NYSE:KBH) Q3 CY2026 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations

KB Home (NYSE: KBH) reported Q3 CY2026 revenue of $1.30B, meeting expectations but down 20% YoY. Full-year guidance of $5B missed estimates by 2%. EPS of $1.05 beat estimates by 16.7%. The company highlighted progress in its Built to Order business and community count growth. Analysts expect 6.5% revenue growth and 19.7% EPS growth over the next 12 months.

$KBHHigh

Why is KB Home stock sliding today?

KB Home stock fell 2.7% in after-hours trading after reporting fiscal Q3 earnings. EPS beat estimates at $1.05, but revenue of $1.3B dropped 20% YoY. Full-year revenue guidance was 2% below expectations. Operating and gross profit margins declined, and net orders fell 12% YoY. The company cited weakening conditions and higher mortgage rates. Ending backlog rose, and $50M in stock was repurchased. The stock had already declined over 20% in the past year.